The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Brain metastases in patients with pleural mesothelioma receiving dual checkpoint blockade compared to single-agent checkpoint blockade or chemotherapy.
 
Margaret Stalker
No Relationships to Disclose
 
Suzanne Walker
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I); Pfizer; Pfizer (I)
 
Emily S. Lebow
Stock and Other Ownership Interests - Oncia Technologies
 
Evan P. Anderson
No Relationships to Disclose
 
Leonid Roshkovan
Research Funding - Genmab (Inst)
 
Sharyn I. Katz
Consulting or Advisory Role - Trizell
Research Funding - Novartis
 
Leslie Litzky
No Relationships to Disclose
 
Andrew R. Haas
Stock and Other Ownership Interests - Serpex Medical
Honoraria - Novocure; VisionAir
Consulting or Advisory Role - Olympus
 
Sunil Singhal
Employment - Morphimmune
Leadership - Morphimmune
Stock and Other Ownership Interests - Morphimmune
 
Corey J. Langer
Honoraria - AstraZeneca; Genentech/Roche; Lilly/ImClone; Merck; Takeda Science Foundation
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Merck; Novocure; Pfizer; Regeneron; Takeda
Research Funding - Advantagene (Inst); Amgen; Ariad (Inst); AstraZeneca; Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte; Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen; Lilly; Merck (Inst); Stem CentRx (Inst); Trizell (Inst)
Other Relationship - Amgen; Lilly; OncoCyte; Peregrine Pharmaceuticals; Summit Therapeutics; Synta
 
Keith A. Cengel
Stock and Other Ownership Interests - symphotek
Consulting or Advisory Role - Novocure
Patents, Royalties, Other Intellectual Property - US20190099491A1 Sensitizing Cells to Proton Radiation; US9999779B2 Cell, tissue and organ protection using a magnetic field
 
Melina Elpi Marmarelis
Stock and Other Ownership Interests - Johnson & Johnson; Merck
Honoraria - AstraZeneca; Blueprint Medicines; Janssen Oncology; Novocure; Takeda; Thermo Fisher Scientific
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bristol-Myers Squibb/Celgene; Ikena Oncology; Janssen Oncology; Regeneron
Research Funding - AstraZeneca (Inst); Genentech (Inst); Ikena Oncology (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Regeneron